PAR-19-198: Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)

NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) PAR-19-198. NCI

Read the full article here

Related Articles